Company Filing History:
2 out of 123 
2 out of 263 
1 out of 448 
Years Active: 2017-2024
Title: The Innovative Contributions of Darren James Dixon
Introduction
Darren James Dixon is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of isoindolinone derivatives. With a total of three patents to his name, his work has the potential to impact cancer treatment and related therapies.
Latest Patents
Dixon's latest patents include innovative processes for preparing isoindolin-1-one derivatives. One of his key inventions focuses on the preparation of (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. This invention also encompasses crystalline forms of the compound and its salts, which could play a crucial role in inhibiting the MDM2-P53 interaction, a significant pathway in cancer biology.
Career Highlights
Throughout his career, Darren has worked with esteemed organizations such as Astex Therapeutics Limited and Cancer Research Technology Limited. His experience in these companies has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Dixon has had the opportunity to work alongside talented individuals such as Steven Howard and Jeffrey David St Denis. These collaborations have further enriched his research and innovation efforts.
Conclusion
Darren James Dixon's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and related therapies.